BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34140506)

  • 21. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
    Baer R
    Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia.
    Mets E; Van der Meulen J; Van Peer G; Boice M; Mestdagh P; Van de Walle I; Lammens T; Goossens S; De Moerloose B; Benoit Y; Van Roy N; Clappier E; Poppe B; Vandesompele J; Wendel HG; Taghon T; Rondou P; Soulier J; Van Vlierberghe P; Speleman F
    Leukemia; 2015 Apr; 29(4):798-806. PubMed ID: 25231743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.
    Sanda T; Lawton LN; Barrasa MI; Fan ZP; Kohlhammer H; Gutierrez A; Ma W; Tatarek J; Ahn Y; Kelliher MA; Jamieson CH; Staudt LM; Young RA; Look AT
    Cancer Cell; 2012 Aug; 22(2):209-21. PubMed ID: 22897851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines.
    Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; MacLeod RA
    Leuk Res; 2010 Apr; 34(4):521-8. PubMed ID: 19608273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional activation of prostate specific homeobox gene NKX3-1 in subsets of T-cell lymphoblastic leukemia (T-ALL).
    Nagel S; Ehrentraut S; Tomasch J; Lienenklaus S; Schneider B; Geffers R; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
    PLoS One; 2012; 7(7):e40747. PubMed ID: 22848398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Products of the TAL2 oncogene in leukemic T cells: bHLH phosphoproteins with DNA-binding activity.
    Xia Y; Hwang LY; Cobb MH; Baer R
    Oncogene; 1994 May; 9(5):1437-46. PubMed ID: 8152805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines.
    Nagel S; Meyer C; Quentmeier H; Kaufmann M; Drexler HG; MacLeod RA
    Leukemia; 2008 Mar; 22(3):600-7. PubMed ID: 18079734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias.
    Speleman F; Cauwelier B; Dastugue N; Cools J; Verhasselt B; Poppe B; Van Roy N; Vandesompele J; Graux C; Uyttebroeck A; Boogaerts M; De Moerloose B; Benoit Y; Selleslag D; Billiet J; Robert A; Huguet F; Vandenberghe P; De Paepe A; Marynen P; Hagemeijer A
    Leukemia; 2005 Mar; 19(3):358-66. PubMed ID: 15674412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32).
    Su XY; Della-Valle V; Andre-Schmutz I; Lemercier C; Radford-Weiss I; Ballerini P; Lessard M; Lafage-Pochitaloff M; Mugneret F; Berger R; Romana SP; Bernard OA; Penard-Lacronique V
    Blood; 2006 Dec; 108(13):4198-201. PubMed ID: 16926283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
    Ferrando AA; Neuberg DS; Dodge RK; Paietta E; Larson RA; Wiernik PH; Rowe JM; Caligiuri MA; Bloomfield CD; Look AT
    Lancet; 2004 Feb; 363(9408):535-6. PubMed ID: 14975618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HOXA-activated early T-cell progenitor acute lymphoblastic leukemia: predictor of poor outcome?
    Meijerink JP; Canté-Barrett K; Vroegindeweij E; Pieters R
    Haematologica; 2016 Jun; 101(6):654-6. PubMed ID: 27252509
    [No Abstract]   [Full Text] [Related]  

  • 32. Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children's Cancer Group Study.
    Uckun FM; Yang Z; Sather H; Steinherz P; Nachman J; Bostrom B; Crotty L; Sarquis M; Ek O; Zeren T; Tubergen D; Reaman G; Gaynon P
    Blood; 1997 May; 89(10):3769-77. PubMed ID: 9160683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancer.
    Smith C; Goyal A; Weichenhan D; Allemand E; Mayakonda A; Toprak U; Riedel A; Balducci E; Manojkumar M; Pejkovska A; Mücke O; Sollier E; Bakr A; Breuer K; Lutsik P; Hermine O; Spicuglia S; Asnafi V; Plass C; Touzart A
    Haematologica; 2023 May; 108(5):1259-1271. PubMed ID: 36632736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements.
    Homminga I; Vuerhard MJ; Langerak AW; Buijs-Gladdines J; Pieters R; Meijerink JP
    Haematologica; 2012 Feb; 97(2):258-61. PubMed ID: 22058201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia.
    Xia Y; Brown L; Yang CY; Tsan JT; Siciliano MJ; Espinosa R; Le Beau MM; Baer RJ
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11416-20. PubMed ID: 1763056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.
    Armstrong SA; Staunton JE; Silverman LB; Pieters R; den Boer ML; Minden MD; Sallan SE; Lander ES; Golub TR; Korsmeyer SJ
    Nat Genet; 2002 Jan; 30(1):41-7. PubMed ID: 11731795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.
    Ferrando AA; Neuberg DS; Staunton J; Loh ML; Huard C; Raimondi SC; Behm FG; Pui CH; Downing JR; Gilliland DG; Lander ES; Golub TR; Look AT
    Cancer Cell; 2002 Feb; 1(1):75-87. PubMed ID: 12086890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. microRNAs regulate TAL1 expression in T-cell acute lymphoblastic leukemia.
    Correia NC; Melão A; Póvoa V; Sarmento L; Gómez de Cedrón M; Malumbres M; Enguita FJ; Barata JT
    Oncotarget; 2016 Feb; 7(7):8268-81. PubMed ID: 26882564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
    Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
    Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The (4;11)(q21;p15) translocation fuses the NUP98 and RAP1GDS1 genes and is recurrent in T-cell acute lymphocytic leukemia.
    Hussey DJ; Nicola M; Moore S; Peters GB; Dobrovic A
    Blood; 1999 Sep; 94(6):2072-9. PubMed ID: 10477737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.